Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes
Aims. To elucidate the levels of malondialdehyde-modified LDL (MDA-LDL)-related variables for predicting coronary artery stenosis (CAS) by coronary CT angiography (CCTA) in asymptomatic patients with type 2 diabetes (T2DM). Methods. Enrolled were 36 Japanese patients with T2DM who underwent CCTA and...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2015/507245 |
id |
doaj-c8d167e2a79b491093356346d635f669 |
---|---|
record_format |
Article |
spelling |
doaj-c8d167e2a79b491093356346d635f6692020-11-24T21:17:16ZengHindawi LimitedJournal of Diabetes Research2314-67452314-67532015-01-01201510.1155/2015/507245507245Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 DiabetesKazuya Fujihara0Hiroaki Suzuki1Akira Sato2Satoru Kodama3Yoriko Heianza4Kazumi Saito5Hitoshi Iwasaki6Kazuto Kobayashi7Shigeru Yatoh8Akimitsu Takahashi9Naoya Yahagi10Hiroaki Yagyu11Hirohito Sone12Hitoshi Shimano13Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, JapanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, JapanDivision of Cardiology, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, JapanDepartment of Hematology, Endocrinology and Metabolism, School of Medicine, Niigata University, Niigata, Niigata 951-8510, JapanDepartment of Hematology, Endocrinology and Metabolism, School of Medicine, Niigata University, Niigata, Niigata 951-8510, JapanDivision of Endocrinology and Metabolism, Center for Medical Sciences, Ibaraki Prefectural University of Health Sciences, Ami, Ibaraki 300-0331, JapanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, JapanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, JapanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, JapanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, JapanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, JapanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, JapanDepartment of Hematology, Endocrinology and Metabolism, School of Medicine, Niigata University, Niigata, Niigata 951-8510, JapanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, JapanAims. To elucidate the levels of malondialdehyde-modified LDL (MDA-LDL)-related variables for predicting coronary artery stenosis (CAS) by coronary CT angiography (CCTA) in asymptomatic patients with type 2 diabetes (T2DM). Methods. Enrolled were 36 Japanese patients with T2DM who underwent CCTA and in whom MDA-LDL levels were measured. Definition of CAS was luminal narrowing of ≥50%. Trends through tertiles of each MDA-LDL-related variable were analyzed with a general linear model. The ability of each MDA-LDL-related variable to predict CAS was compared to areas under the curve (AUCs) in receiver operating characteristic curve (ROC) analysis. Results. Seventeen patients had CAS. Each MDA-LDL-related variable was an independent predictor of CAS (P=0.039 for MDALDL, P=0.013 for MDA-LDL/LDL-C, P=0.047 for MDA-LDL/HDL-C, and P=0.013 for (MDA-LDL/LDL-C)/HDL-C). AUCs of MDA-LDL, MDA-LDL/LDL-C, MDA-LDL/HDL-C, and (MDA-LDL/LDL-C)/HDL-C were 0.675 (95% CI 0.496–0.854), 0.765 (0.602–0.927), 0.752 (0.592–0.913), and 0.799 (0.643–0.955), respectively, for predicting CAS. Trends throughout the tertiles showed significant associations between MDA-LDL/LDL-C, MDA-LDL/HDL-C, or (MDALDL/LDL-C)/HDL-C and CAS (P=0.003 for MDA-LDL/LDL-C, P=0.042 for MDA-LDL/HDL-C, and P=0.001 for (MDA-LDL/LDL-C)/HDL-C). Conclusions. Data suggest that measurements of MDA-LDL/LDL-C, MDA-LDL/HDLC, and (MDA-LDL/LDL-C)/HDL-C are useful for predicting CAS.http://dx.doi.org/10.1155/2015/507245 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kazuya Fujihara Hiroaki Suzuki Akira Sato Satoru Kodama Yoriko Heianza Kazumi Saito Hitoshi Iwasaki Kazuto Kobayashi Shigeru Yatoh Akimitsu Takahashi Naoya Yahagi Hiroaki Yagyu Hirohito Sone Hitoshi Shimano |
spellingShingle |
Kazuya Fujihara Hiroaki Suzuki Akira Sato Satoru Kodama Yoriko Heianza Kazumi Saito Hitoshi Iwasaki Kazuto Kobayashi Shigeru Yatoh Akimitsu Takahashi Naoya Yahagi Hiroaki Yagyu Hirohito Sone Hitoshi Shimano Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes Journal of Diabetes Research |
author_facet |
Kazuya Fujihara Hiroaki Suzuki Akira Sato Satoru Kodama Yoriko Heianza Kazumi Saito Hitoshi Iwasaki Kazuto Kobayashi Shigeru Yatoh Akimitsu Takahashi Naoya Yahagi Hiroaki Yagyu Hirohito Sone Hitoshi Shimano |
author_sort |
Kazuya Fujihara |
title |
Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes |
title_short |
Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes |
title_full |
Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes |
title_fullStr |
Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes |
title_full_unstemmed |
Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes |
title_sort |
circulating malondialdehyde-modified ldl-related variables and coronary artery stenosis in asymptomatic patients with type 2 diabetes |
publisher |
Hindawi Limited |
series |
Journal of Diabetes Research |
issn |
2314-6745 2314-6753 |
publishDate |
2015-01-01 |
description |
Aims. To elucidate the levels of malondialdehyde-modified LDL (MDA-LDL)-related variables for predicting coronary artery stenosis (CAS) by coronary CT angiography (CCTA) in asymptomatic patients with type 2 diabetes (T2DM). Methods. Enrolled were 36 Japanese patients with T2DM who underwent CCTA and in whom MDA-LDL levels were measured. Definition of CAS was luminal narrowing of ≥50%. Trends through tertiles of each MDA-LDL-related variable were analyzed with a general linear model. The ability of each MDA-LDL-related variable to predict CAS was compared to areas under the curve (AUCs) in receiver operating characteristic curve (ROC) analysis. Results. Seventeen patients had CAS. Each MDA-LDL-related variable was an independent predictor of CAS (P=0.039 for MDALDL, P=0.013 for MDA-LDL/LDL-C, P=0.047 for MDA-LDL/HDL-C, and P=0.013 for (MDA-LDL/LDL-C)/HDL-C). AUCs of MDA-LDL, MDA-LDL/LDL-C, MDA-LDL/HDL-C, and (MDA-LDL/LDL-C)/HDL-C were 0.675 (95% CI 0.496–0.854), 0.765 (0.602–0.927), 0.752 (0.592–0.913), and 0.799 (0.643–0.955), respectively, for predicting CAS. Trends throughout the tertiles showed significant associations between MDA-LDL/LDL-C, MDA-LDL/HDL-C, or (MDALDL/LDL-C)/HDL-C and CAS (P=0.003 for MDA-LDL/LDL-C, P=0.042 for MDA-LDL/HDL-C, and P=0.001 for (MDA-LDL/LDL-C)/HDL-C). Conclusions. Data suggest that measurements of MDA-LDL/LDL-C, MDA-LDL/HDLC, and (MDA-LDL/LDL-C)/HDL-C are useful for predicting CAS. |
url |
http://dx.doi.org/10.1155/2015/507245 |
work_keys_str_mv |
AT kazuyafujihara circulatingmalondialdehydemodifiedldlrelatedvariablesandcoronaryarterystenosisinasymptomaticpatientswithtype2diabetes AT hiroakisuzuki circulatingmalondialdehydemodifiedldlrelatedvariablesandcoronaryarterystenosisinasymptomaticpatientswithtype2diabetes AT akirasato circulatingmalondialdehydemodifiedldlrelatedvariablesandcoronaryarterystenosisinasymptomaticpatientswithtype2diabetes AT satorukodama circulatingmalondialdehydemodifiedldlrelatedvariablesandcoronaryarterystenosisinasymptomaticpatientswithtype2diabetes AT yorikoheianza circulatingmalondialdehydemodifiedldlrelatedvariablesandcoronaryarterystenosisinasymptomaticpatientswithtype2diabetes AT kazumisaito circulatingmalondialdehydemodifiedldlrelatedvariablesandcoronaryarterystenosisinasymptomaticpatientswithtype2diabetes AT hitoshiiwasaki circulatingmalondialdehydemodifiedldlrelatedvariablesandcoronaryarterystenosisinasymptomaticpatientswithtype2diabetes AT kazutokobayashi circulatingmalondialdehydemodifiedldlrelatedvariablesandcoronaryarterystenosisinasymptomaticpatientswithtype2diabetes AT shigeruyatoh circulatingmalondialdehydemodifiedldlrelatedvariablesandcoronaryarterystenosisinasymptomaticpatientswithtype2diabetes AT akimitsutakahashi circulatingmalondialdehydemodifiedldlrelatedvariablesandcoronaryarterystenosisinasymptomaticpatientswithtype2diabetes AT naoyayahagi circulatingmalondialdehydemodifiedldlrelatedvariablesandcoronaryarterystenosisinasymptomaticpatientswithtype2diabetes AT hiroakiyagyu circulatingmalondialdehydemodifiedldlrelatedvariablesandcoronaryarterystenosisinasymptomaticpatientswithtype2diabetes AT hirohitosone circulatingmalondialdehydemodifiedldlrelatedvariablesandcoronaryarterystenosisinasymptomaticpatientswithtype2diabetes AT hitoshishimano circulatingmalondialdehydemodifiedldlrelatedvariablesandcoronaryarterystenosisinasymptomaticpatientswithtype2diabetes |
_version_ |
1726013217839251456 |